Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Restriction On Generic Drug Switches In DEA eRx Proposal Draws Criticism

Executive Summary

A provision in the Drug Enforcement Administration's proposed rule for electronic prescribing of controlled substances that would prohibit pharmacists from substituting generic drugs for brand name drugs is drawing fire from various stakeholders

You may also be interested in...



Generic Substitution Of Controlled Drugs Allowed In DEA e-Prescribing Rule

The Drug Enforcement Administration says generic substitution of controlled substances will be allowed at the pharmacy level when the prescription is submitted electronically

Generic Substitution Of Controlled Drugs Allowed In DEA e-Prescribing Rule

The Drug Enforcement Administration says generic substitution of controlled substances will be allowed at the pharmacy level when the prescription is submitted electronically

E-prescribing Rising: More Docs Requesting Patient Rx Benefit, History Info

Volume of electronic prescribing increased by 118 percent from 2008 to 2009.

Related Content

UsernamePublicRestriction

Register

LL1135544

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel